Materials and Methods

Mutagenesis and expression of GlyR cDNAs
The human GlyR α1 subunit cDNA was subcloned into the pCIS2 plasmid vector. The human α2 subunit, which was kindly provided by Dr Paul Groot-Kormelink (University College, London, UK), was subcloned into the pcDNA3.1 plasmid vector (Invitrogen). The rat α3 subunit was also subcloned into the pcDNA3.1 plasmid vector. The human β subunit was subcloned into the pIRES2-EGFP plasmid vector (Clontech, Palo Alto, CA, USA). Site-directed mutagenesis was performed using the QuickChange mutagenesis kit (Stratagene, La Jolla, CA, USA) and the successful incorporation of mutations was confirmed by sequencing the clones. The only exception was the α1 G2'S mutant GlyR, which was kindly provided by Dr. Malcolm Slaughter (University of Buffalo, NY, USA). HEK293 cells, cultured in Dulbecco's Modified Eagles Medium, were transfected using a calcium phosphate precipitation protocol. When co-transfecting the GlyR α and β subunits, their respective cDNAs were combined in a ratio of 1:20. After exposure to transfection solution for 24 hrs, cells were washed twice in calcium-free phosphate buffered saline and used for recording over the following 24 -72 hrs.
Electrophysiology
Cells were visualised using an inverted fluorescent microscope and currents were measured by whole cell patch-clamp recording. Cells were perfused by a control solution that contained (in mM): 140 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, 10 glucose, with the pH adjusted to 7.4 with NaOH. Patch pipettes were fabricated from borosilicate hematocrit tubing (Vitrex, Modulohm, Denmark) and heat polished. Pipettes had a tip resistance of 1 -2 MΩ when filled with the standard pipette solution which contained (in mM): 145 CsCl, 2 CaCl 2 , 2 MgCl 2 , 10 HEPES, 10 EGTA, with the pH adjusted to 7.4 with NaOH. After establishment of the whole cell configuration, cells were voltage-clamped at -40 mV (unless otherwise indicated) and membrane currents were recorded using an Axopatch 1D amplifier and pCLAMP9 software (Axon Instruments, Union City, CA, USA). The cells were perfused by a parallel array of microtubular barrels through which solutions were gravity-induced. All experiments were conducted at room temperature (19 -22 o C).
Because α homomers can form functional GlyRs, it is necessary to confirm the incorporation of β subunits into functional αβ heteromers. As the GlyR β subunit cDNA was cloned into the pIRES2-EGFP plasmid vector, we used GFP fluorescence to identify cells expressing the GlyR β subunit. The successful incorporation of β subunits into functional heteromeric GlyRs was inferred by characteristic changes in sensitivity to PTXININ and PTN as described below. PTXININ and PTN were obtained from Sigma (St Louis, MO, USA) and were stored frozen as a 100 mM stocks in dimethylsulfoxide.
Data Analysis
Results are expressed as mean ± standard error of the mean of 3 or more independent experiments. The Hill equation was used to calculate the saturating current magnitude (I max ), halfmaximal concentration (EC 50 ) and Hill coefficient (n H ) values for glycine activation. A similar equation
was also used to calculate the half maximal concentrations for inhibition (IC 50 ) and n H values of the antagonists tested in this study. All curves were fitted using a non-linear least squares algorithm (Sigmaplot 9.0, Jandel Scientific, San Rafael, CA, USA). Statistical significance was determined by paired or unpaired Student's t-test, as appropriate, with P < 0.05 representing significance.
Molecular modelling
A pentameric model of the region from -2' to 19' of M2 of the GlyR α1 subunit was built as described previously (Hawthorne et al. 2006) , by homology with the equivalent region of the nAChR α subunit in the electron microscopy-derived closed-channel structure, (pdb code 1OED) (Miyazawa et al. Handford et al. 1996; Shan et al. 2001; Miller et al. 2004) , except for those of the α3 and α3β GlyRs which are several fold higher than previously reported (Meier et al. 2005; Miller et al. 2005) . The reasons for this are unknown. The averaged glycine dose-response relationships for GlyRs incorporating mutations to the 2' pore-lining position (i.e., α1 G2'P , α1
G2'A , α1 G2'S and α1β
P2'G
) and the 6' pore-lining position (i.e., α1
) are shown in Fig. 2C and D, respectively. Averaged parameters of best fit to all dose-response curves are shown in Table 1 .
PTXININ and PTN sensitivity of GlyRs mutated at the 6' position
As shown in the M2 domain sequence alignment in Fig. 3 , the T6' residue is highly conserved among anionic cys-loop receptors (Fig. 3) . Indeed, a ring of five T6' residues has been shown to be essential for high affinity PTXININ inhibition (Gurley et al. 1995; Shan et al. 2001 Shan et al. , 2002 Sedelnikova et al. 2006) . Molecular modelling studies on homomeric α1 GlyRs, ρ1 GABA A Rs and β3 GABA A Rs predict that T6' hydroxyl groups form hydrogen bonds with oxygens common to both PTXININ and PTN (Zhorov and Bregestovski 2000; Chen et al. 2006) . Because the earlier modelling of the interaction between PTXININ and the GlyR pore (Zhorov and Bregestovski 2000) was performed prior to the determination of the nAChR pore structure at 4 Å resolution (Miyazawa et al. 2003; Unwin 2005) , we have re-investigated this interaction using a model homomeric α1 GlyR pore based on this new structural template. The model was generated as described above and computational docking was used to assess feasible binding sites for PTXININ and PTN within the pore lumen. The vast majority of the docked conformations for PTXININ were in contact with T6' residues, including a major cluster within 1.5 Å rmsd comprising 40% of the total. For all docks within this cluster, there were two or three hydrogen bonds between T6' residues and the exocyclic oxygens common to PTXININ and PTN, whereas the isopropenyl group of PTXININ, the point of variation with PTN, was in closer proximity to the G2' residues ( Fig. 3B, left) . Both of these features are consistent with PTXININ docking in the β3 GABA A R homomer (Chen et al. 2006 ) and broadly consistent with the earlier GlyR study (Zhorov and Bregestovski 2000) . Computational docking of PTN within our model GlyR pore showed a greater variety of conformations, apparently due to the additional hydrogen bonding capacity of its unique dimethyl-methanol group. Nevertheless, a significant cluster overlapped closely with the major PTXININ cluster, with similar hydrogen bonds and the dimethyl-methanol group positioned close to the G2' residues ( Fig. 3B, right ).
If this model is correct, then 6' mutations should equally affect GlyR sensitivity to PTXININ and PTN. To test this hypothesis, we compared the IC 50 values of PTXININ and PTN at the α1
T6'A and α1 T6'V GlyRs. The T6'F mutation (the α to β subunit substitution) was tested as it is known to cause a significant reduction in PTX sensitivity but does not abolish it completely (Shan et al. 2001; Sedelnikova et al. 2006) . We also tested the T6'A and T6'S mutations, which are more conservative substitutions for threonine residues. The T6'A substitution removes the hydroxyl group (thereby the hydrogen bond donor) of the threonine side chain, whereas the T6'S mutation specifically eliminates the methyl group. Finally, we investigated the T6'V mutation. This replaces the threonine hydroxyl group with a non-polar methyl group.
In all experiments, the PTXININ and PTN inhibitory dose-response relationships were measured at the glycine EC 50 value as listed in Table 2 . Examples of the effects of increasing concentrations of PTXININ and PTN on α1 GlyR currents, together with averaged inhibitory dose-response relationships, are shown in Fig. 4A . The averaged parameters of best fit summarised in Table 2 . This result confirms the previous finding (Lynch et al. 1995 ) that α1 GlyRs are equally sensitive to both compounds. The corresponding results for the α1 T6'F GlyR, shown in Fig. 4B , reveal a significantly decreased receptor sensitivity to both PTXININ and PTN, although the α1 T6'F GlyR remained equally sensitive to both compounds. Although full dose-responses could not be generated due to its low sensitivity to both compounds, we found that 100 µM PTXININ and PTN reduced α1 T6'F GlyR current by 30 ± 5 % and 35
± 7 % (n = 5 for each), respectively. The T6'A, T6'S and T6'V mutations completely eliminated GlyR sensitivity to both PTXININ and PTN (Fig. 4B , Table 2 ). As all three mutations are conservative substitutions, their effects on PTXININ and PTN sensitivity are presumably reasonably specific in disrupting the hydrogen bonding and hydrophobic interaction capabilities of T6' side chains. The finding that the T6'V and T6'S mutations both eliminated sensitivity to PTXININ and PTN implies that both hydrogen bonds and hydrophobic interactions are important determinants of their sensitivity. The predicted roles of T6' side chains in coordinating PTXININ and PTN are considered further in the Discussion. Overall, the results so far provide strong evidence that the GlyR T6' side chains coordinate PTXININ and PTN via molecular groups common to both molecules.
PTXININ and PTN sensitivity of GlyRs mutated at the 2' position
Despite their similar structures, PTXININ is much more potent than PTN at inhibiting GABA A Rs in vivo (Jarboe et al. 1968) . Consistent with earlier studies of GlyRs and GABA A Rs (Zhorov and Bregestovski 2000; Chen et al. 2006) , our modelling studies predict that the non-conserved groups of PTXININ and PTN come into close contact with the GlyR 2' residues ( Fig. 3B ). GABA A Rs usually have alanines, valines or serines at the 2' position, which are all larger than the 2' glycine of the α1GlyR (Fig.   3 ). One modelling study predicted that the 2' alanine methyl group of homomeric β3 GABA A Rs forms hydrophobic interactions with the isopropenyl group of PTXININ (Chen et al. 2006) . Such interactions are likely to be less favourable with the more hydrophilic dimethyl-methanol group of PTN. The small 2' glycine of the α1GlyR would eliminate such interactions, but may permit backbone groups to contribute to hydrogen bonds or hydrophobic interactions in a manner that permits energetically equivalent interactions with both blockers (Zhorov and Bregestovski 2000) . An alternate or additional possibility is that the small glycine side chain enables both molecules to sterically fit equally well at this level of the pore. Based on all these considerations, we hypothesised that the G2'A substitution in the α1 GlyR should result in an increased sensitivity to PTXININ and a decreased sensitivity to PTN.
The amino acid sequences of α1 and α2 GlyR M2 domains are identical with the exception of a G2'A substitution in the α2 subunit (Fig. 3) . As shown in Fig. 5A , the α2 GlyR indeed exhibited a remarkably increased sensitivity to PTXININ and a modestly reduced sensitivity to PTN ( Table 2 ). As expected, the PTXININ and PTN sensitivities of the α1 G2'A GlyR were similar to those of the α2 GlyR (Fig. 5B , Table 2 ). Thus, the differential sensitivity of the α1 and α2 GlyRs is due to the amino acid difference at the 2' position. This confirms the model predictions that the 2' residue is important for distinguishing between these 2 molecules.
In an attempt to discern the molecular basis by which this discrimination occurs, we investigated the PTXININ and PTN sensitivities of the α1 G2'S GlyR. Serine is larger and more hydrophilic than alanine. If side chain volume dominates the process by which the α1 G2'A GlyR distinguishes PTXININ from PTN, then the α1 G2'S GlyR should be more sensitive to PTXININ than PTN. If side chain polarity dominates the selectivity process, however, then the α1 G2'S GlyR should be more sensitive to the more polar PTN than to PTXININ. As shown in Fig. 5C and summarised in Table 2 , PTXININ remains much more potent than PTN as an inhibitor of the α1 G2'S GlyR. This suggests that the space available at the 2' region is more important than 2' binding interactions in discriminating between PTXININ and PTN.
However, the increased PTXININ sensitivity of the α1 G2'A GlyR relative to the α1 GlyR implies that hydrophobic interactions improve the binding of PTXININ to receptors containing 2' alanines.
Role of the β subunit
The GlyR β subunit shares an unusually low amino acid homology with the M2 domains of all other anionic cys-loop receptor subunits (Fig. 3) . Of particular relevance to the present study, this subunit contains non-conserved proline and phenylalanine groups at the 2' and 6' positions, respectively.
Heteromeric αβ GlyRs are believed to exist in a 2α:3β stoichiometry (Grudzinska et al. 2005) , implying the existence of prolines at three of the five 2' positions. Given the large size of the 2' proline relative to glycine and the conclusion above that steric volume at least partly mediates α2 GlyR discrimination between PTXININ and PTN, it might be expected that the α1β GlyR should be more sensitive to PTXININ than PTN. We found, however, that the α1β GlyR was equally sensitive to both compounds (Fig. 6A, Table 2 ) in contrast to the homomeric α1 G2'P GlyR, which was one hundred-fold more sensitive to PTXININ than PTN (Fig. 6A, Table 2 ). One possible explanation is that in α1β GlyRs, the α1 G2' residues create sufficient space for PTN binding despite the prolines at the 2' position in the β subunit.
Alternatively, the other differences in the β subunit may have broader effects on the overall structure of the pore, increasing the space available at the 2' position. To differentiate between these alternatives, we investigated the PTXININ and PTN sensitivities of the α1β P2'G GlyR, which restores the ring of 2'
glycines, but incorporates the β subunit. As shown in Fig. 6C , the α1β P2'G GlyR exhibits a drastically decreased sensitivity to PTN relative to PTXININ, the reverse of what occurs in homomeric α1 GlyRs when a ring of 2' glycines is present. These results imply that the β subunit as a whole imposes a structural change that alters the structure of the 2' -6' binding site. Consequently, we conclude that the determinants of PTXININ and PTN binding to the α1 homomeric GlyR do not apply directly to the α1β GlyR. Investigation of the heteromeric receptor discriminatory mechanism will be complicated by the low sequence homology between the β and α1 subunits (Fig. 3A) and the difficulty in ascertaining the functional expression of β subunits with increased sensitivities to PTXININ and PTN.
PTXININ and PTN as GlyR subunit-specific pharmacological probes
Glycinergic synapses on neurons in spinal cord dorsal horn nociceptive pathways comprise either α1β or α3β GlyRs or a mixture of both (Harvey et al. 2004; Zeilhofer et al. 2005 ). It is not yet possible to define the respective roles of these receptors in pain signalling because few, if any, compounds are known to selectively discriminate between α1-and α3-containing GlyRs (Webb and Lynch 2007) . As α3 GlyR subunits contain an alanine at the 2' position ( Fig. 3) , we hypothesised that α3β GlyRs may be pharmacologically differentiated from α1β GlyRs by a differential sensitivity to PTXININ and PTN.
Accordingly, we measured the PTXININ and PTN inhibitory dose-responses at the homomeric α3 GlyR and the heteromeric α3β GlyR. The results, summarised in Fig. 7 and Table 2, confirm that α3 and α3β GlyRs are both more sensitive to PTXININ than to PTN. In Fig. 7A and B, the corresponding PTXININ and PTN dose-response curves for the α1 and α1β GlyRs, respectively, are included as dashed lines for comparison. The α1β and α3β GlyRs share a similar sensitivity to PTN, although α3β GlyRs are significantly more sensitive than α1β GlyRs to PTXININ.
Table 2 also shows that the α3 homomeric GlyR is much more sensitive than the α3β heteromeric GlyR to PTXININ. This compound thus provides a better tool than PTX or PTN for discriminating between these two isoforms in heterologous expression systems.
Discussion
Structural basis of PTXININ and PTN binding in the homomeric α1 GlyR pore
Mutations can affect antagonist IC 50 values either by directly modifying ligand binding sites or by non-specific structural disruptions. Comparing the effects of two blockers with closely related structures can help to discriminate between these possibilities. The reasoning for this is that non-specific structural disruptions should have similar effects on the binding of two molecules with closely related structures provided that they interact with the receptor through multiple similar binding interactions.
Thus, the fact that 2' mutations had differential effects on GlyR sensitivity to PTXININ and PTN suggests direct interactions between residues at the 2' pore-lining position and the non-conserved molecular groups on these molecules.
Threonine residues can contribute to both hydrogen bonds (via their hydroxyl groups) and to hydrophobic interactions (via their methyl groups). Selective elimination of the 6' threonine hydrophobic interacting capability via the structurally-conservative T6'S mutation, of their hydrogen bonding capability by the T6'V mutation, and of both by the T6'A mutation, completely eliminated sensitivity to both PTXININ and PTN in homomeric α1 GlyRs. These results imply that both hydrophobic interactions and hydrogen bonds contributed by 6' threonine residues are important for coordinating PTXININ and PTN. The α1 subunit T6'F mutation strongly reduced receptor sensitivity to both compounds but did not eliminate it (Fig. 4B ). As this substitution also eliminates the hydrogen bonding capacity of the 6' side chain, it might be expected that it should also eliminate the ability of both compounds to bind in the pore.
The fact that it does not implies that the larger phenylalanine side chain imposes a non-specific structural disruption that partially compensates for the loss in affinity caused by elimination of the hydrophobic interaction capability. Nevertheless, the T6'F result is significant as it is an example of a 6' mutation that equally affects receptor sensitivity to PTXININ and PTN. Together, these results allow us to conclude that 6' threonines coordinate PTXININ and PTN via molecular groups common to both molecules.
Molecular modelling reveals the three common exocyclic oxygens to be the most likely hydrogen bond receivers.
As mutations to 2' residues have differential effects on receptor sensitivity to PTXININ and PTN, we conclude that the non-conserved regions of PTXININ and PTN are located directly adjacent to this part of the pore. It is worth reconsidering the structural differences between the molecules. PTN is larger than PTXININ by the size of a water molecule. The PTN dimethyl-methanol group can contribute to hydrophobic interactions via its two methyl groups and to hydrogen bonds via its hydroxyl group, whereas the PTXININ isopropenyl group is capable of forming only hydrophobic interactions. The two molecules can thus be discriminated on the basis of size, chemical bonding properties, or both.
The homomeric α1 GlyR contains a ring of small 2' glycine residues which expose both polar and non-polar backbone groups to the pore lumen. The G2'S substitution, which adds a hydrogen bond donor to the side chain, had no effect on sensitivity to PTXININ but drastically reduced sensitivity to PTN. This result strongly suggests that PTN is excluded on the basis of its larger size. The G2'A substitution, which also reduces the pore exposure of backbone groups and adds a moderately hydrophobic methyl group to the side chain, significantly increases receptor sensitivity to PTXININ but modestly reduces sensitivity to PTN. This result is also consistent with a size exclusion mechanism but suggests that PTXININ may have enhanced binding to this residue via a hydrophobic interaction.
PTXININ and PTN binding in the heteromeric α1β GlyR pore
Incorporation of the β subunit is known to produce a dramatic (> 20-fold) reduction in PTX sensitivity (Pribilla et al. 1992; Lynch et al. 1995) . In the present study we found that β subunit coexpression produced an approximately 5-fold reduction in α1 GlyR sensitivity to both PTXININ and PTN ( Table 2 ), suggesting that our experiments may have been performed on a mixture of α1 homomeric and α1β heteromeric receptors (Burzomato et al. 2003) . However, this uncertainty does not impinge significantly on our ability to interpret the β subunit results because the presumed receptor mixture exhibited similar sensitivities to PTXININ and PTN whereas the β P2'G mutation caused a significant and selective decrease in PTN sensitivity ( Table 2 ).
The unusually low M2 domain amino acid sequence homology between GlyR β and α subunits implies that heteromeric αβ GlyRs and α homomeric GlyRs have different pore structures. Thus, the above discriminatory mechanism may not necessarily pertain to β subunit-containing GlyRs. Indeed, despite containing three bulky prolines at the 2' position, heteromeric α1β GlyRs are equally sensitive to PTXININ and PTN. When these prolines are replaced by glycines, the α1β P2'G GlyRs retain a relatively high sensitivity to PTXININ but sensitivity to PTN is largely lost. This result cannot be reconciled with the pattern observed with α1 homomeric GlyRs and indicates that the α1β GlyR pore discriminates between PTXININ and PTN via a different mechanism to homomeric α GlyRs. Note that the generally lower PTX sensitivity of α1β heteromeric GlyRs is due to a reduction in the number of 6' threonines, as substitution of β subunit 6' phenylalanines by threonines restores PTX sensitivity (Shan et al. 2001 ).
PTXININ and PTN as pharmacological probes
Inhibition of α3β GlyRs by the inflammatory mediator, prostaglandin E 2 , in spinal cord lamina I neurons results in the disinhibition of firing in nociceptive projection neurons (Ahmadi et al. 2002; Harvey et al. 2004 ). This mechanism may underlie inflammation-induced hyperalgesia or allodynia (Zeilhofer 2005; Lynch and Callister 2006) , and substances that can restore glycinergic neurotransmission in these neurons may have potential as therapeutic lead compounds for chronic inflammatory pain. The α3β and α1β GlyRs are equally represented at lamina I neuronal synapses (Harvey et al. 2004) . Although both receptor subtypes are potential therapeutic targets, their relative contributions to the net glycinergic synaptic current magnitude are as yet unknown. It is also not known why the α3 subunit is highly expressed in these neurons, but is sparsely distributed throughout the rest of the spinal cord (Harvey et al. 2004) . Resolving these questions may provide useful insights into spinal cord pain processing mechanisms. We have shown that the α1β GlyR is equally sensitive to PTXININ and PTN, whereas the α3β GlyR has a three-fold increased sensitivity to PTXININ over PTN. Thus, a comparison of the inhibitory effects of PTN and PTXININ may be useful for estimating the relative contributions of α1β and α3β GlyRs to the net glycinergic synaptic current.
Conclusion
Our results suggest that PTXININ and PTN bind to T6' residues by hydrogen bonding with the three exocyclic double-bonded oxygens common to both molecules. When PTXININ and PTN are coordinated in this position, their variable groups align with the 2' level (Fig. 3B) . We propose that there is minimal chemical bonding with pore-lining groups near the 2' level and that both compounds have equivalent affinities at the homomeric α1 GlyR because the 2' glycine side chain affords sufficient space to accommodate both molecules equally well. However, homomeric α2 and α3 GlyRs and most GABA A R subunits contain larger residues at the 2' position. We propose that these reduce space available at the 2' level, which sterically prevents the larger PTN molecule from adopting its optimal binding position in the pore. The binding of the PTXININ may also be improved by a hydrophobic interaction between the 2' alanine and its unique isoproprenyl group. Thus, homomeric GlyRs, and probably also GABA A Rs, discriminate between PTXININ and PTN primarily on the basis of size. In contrast, heteromeric α1β GlyRs are equally sensitive to PTXININ and PTN despite containing three bulky proline residues at the 2' position. This suggests that the above discriminatory mechanism may not apply to β subunit-containing GlyRs. As α3β GlyRs exhibit a differential sensitivity to PTXININ and PTN whereas α1β GlyRs do not, a comparative analysis of the effect of both compounds may be useful for estimating the relative contributions of α3β and α1β GlyRs to glycinergic inhibition in spinal nociceptive neurons.
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Figure legends
GlyR EC 50 (µM) n H n α1 31 ± 2 2.5 ± 0.4 10 α2 95 ± 7*** 1.9 ± 0.2 5 α3 265 ± 3*** 2.6 ± 0.1 3 α1β 51 ± 9** 1.6 ± 0.2 6 α3β 219 ± 18*** 2.5 ± 0.5 6 * P<0.05, **P<0.01, ***P<0.001 denote significance relative to the α1 GlyR using a Student's unpaired t-test.
